CF Foundation Awards Funding for First-Ever Controlled Clinical Study of Phage Therapy in CF
March 18, 2020
The Cystic Fibrosis Foundation awarded up to $5 million to Armata Pharmaceuticals for the first-ever controlled clinical study of phage therapy in CF, reaffirming the Foundation’s commitment to advance innovative solutions to the growing challenge of antibiotic resistance.